Featured Research

from universities, journals, and other organizations

Economic Cost Of Cancer Mortality Is High In US, Regardless Of How Cost Is Measured

Date:
December 9, 2008
Source:
Journal of the National Cancer Institute
Summary:
The economic cost of death due to cancer is high in the United States, regardless of whether researchers estimate the economic impact in lost work productivity or in a more global measure using the value of one year of life, according to two studies in the Journal of the National Cancer Institute.

The economic cost of death due to cancer is high in the United States, regardless of whether researchers estimate the economic impact in lost work productivity or in a more global measure using the value of one year of life, according to two studies published online December 9 in the Journal of the National Cancer Institute.

Researchers can estimate the economic burden of cancer mortality in terms of lost years of work (the human capital approach) or using the willingness-to-pay approach, which calculates the impact based on how much people would pay to gain one additional year of life ($150,000 based on prior studies in the U.S.).

To gain a more comprehensive understanding of the economic impact of cancer mortality, Robin Yabroff, Ph.D., of the Health Services and Economics Branch of the National Cancer Institute in Bethesda, Md., and colleagues used the willingness-to-pay approach, while Cathy J. Bradley, Ph.D., of Virginia Commonwealth University and the Massey Cancer Center in Richmond, Va., and colleagues used the human capital approach.

In 2000, cancer deaths cost the United States $115.8 billion in lost productivity, Bradley reports. That estimate jumped to $147.6 billion for 2020, due to changes in the population size and age. An annual 1 percent reduction in mortality, compared with current trends from leukemia and lung, breast, colorectal, pancreatic, and brain cancer, would reduce the estimate by $814 million per year. When Bradley and colleagues included the value of caregiving and household duties lost, as well as regular wage earning jobs, the cost of cancer mortality more than doubled to $232.4 billion in 2000 and $308 billion for 2020.

The estimates were even larger when Yabroff and colleagues used the willingness-to-pay approach. In that case, the cost of cancer mortality was $960.7 billion in 2000 and was predicted to be $1,472.5 billion in 2020. An annual decrease in mortality of 2 percent reduced the projected cost of breast cancer mortality from $121.0 billion in 2020 to $80.7 billion, of colorectal cancer from $140.1 billion to $93.5 billion, for lung cancer from $433.4 billion to $289.4 billion, and for prostate cancer from $58.4 billion to $39.0 billion.

Lung cancer alone accounted for 25 percent or more of the costs in the two models.

"Regardless of the method used to estimate the societal value of premature deaths, these mortality costs are an important component of the burden of disease," write Yabroff and colleagues. Moreover, Bradley and colleagues note that the cost of cancer mortality is high when compared with other diseases, such as diabetes or influenza.

"Decision makers can use the information we provide as a basis to assess the costs of inter¬ventions relative to their benefits to determine how to best allocate resources among these strategies," write Bradley and colleagues. "From a productivity loss perspec¬tive, investments in programs that reduce lung, breast, colorectal, leukemia, and/or pancreatic cancer mortality are likely to yield the largest annual reduction in productivity costs for US society."

In an accompanying editorial, Scott Ramsey, M.D., Ph.D., of the Fred Hutchinson Cancer Research Institute in Seattle notes that both papers provide important, but somewhat incomplete, estimates of the cost of cancer. Despite the limitation, the numbers provide important information that can help policy makers. For example, he points out that by either measure the current investment in cancer research in the United States is low. "Clearly, these two studies suggest that the value of that information far exceeds our research investment (the National Cancer Institute's budget for 2008 is about $4.8 billion)," he writes.

"As a tool for advocacy, dollar values can be powerful, particularly when they are weighed against other programs that influence human life and health under limited budgets," he concludes.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "Economic Cost Of Cancer Mortality Is High In US, Regardless Of How Cost Is Measured." ScienceDaily. ScienceDaily, 9 December 2008. <www.sciencedaily.com/releases/2008/12/081209221503.htm>.
Journal of the National Cancer Institute. (2008, December 9). Economic Cost Of Cancer Mortality Is High In US, Regardless Of How Cost Is Measured. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2008/12/081209221503.htm
Journal of the National Cancer Institute. "Economic Cost Of Cancer Mortality Is High In US, Regardless Of How Cost Is Measured." ScienceDaily. www.sciencedaily.com/releases/2008/12/081209221503.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) — Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) — A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) — More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) — Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins